Diagnos Laboratorium Utama Tbk. vs Total Bangun Persada Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.2K 24h volume), while Total Bangun Persada Tbk. trades at Rp1,470 (market cap 4.94T, 4.85M 24h volume). The key difference: Total Bangun Persada Tbk. is far larger — about 15.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Total Bangun Persada Tbk. is more actively traded (4.85M versus 124.2K). Which is the better fit depends on your goals.
| DGNS | TOTL | |
|---|---|---|
Market Cap | 319B | 4.94T |
Volume | 124.2K | 4.85M |
Lot | 1.24K | 48.54K |
Turnover | 28.25M | 7.07B |
Average Price | 227.48 | 1,457.24 |
Value | 28.25M | 7.07B |
Indicative Equilibrium Price | 228 | 1,470 |
Indicative Equilibrium Volume | 100 | 2.2K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Total Bangun Persada (the company) was established under its original name of PT Tjahja Rimba Kentjana on Sep 4, 1970 then changed to PT Total Bangun Persada based on Notaries Deed dated Jul 24, 1981 and the deed of establishment was approved by the the Ministry of Justice dated Nov 4, 1981. The Company’s articles of association has been amended several times, most recently by notarial deed No. 47 of Haryanto, S.H., dated Oct 24, 2005, concerning the amendment of Company's authorized and paid up capital, and public offering.
Read more on TOTL →